Dicerna Pharmaceuticals Inc 4/A SEC Filings

Filed On	Filing
05 Apr 2021	Form 4/A: Brown Bob D, Chief Scientific Ofr., EVP R&D Received 8,312 shares by exercise or conversion ($28.4K)
05 Apr 2021	Form 4/A: Brown Bob D, Chief Scientific Ofr., EVP R&D Received 8,312 shares by exercise or conversion ($26.1K)
05 Apr 2021	Form 4/A: Brown Bob D, Chief Scientific Ofr., EVP R&D Received 16,630 shares by exercise or conversion ($49.4K)
04 Sep 2020	Form 4/A: Weissman James B, Chief Operating Officer & EVP Received 4,360 shares by exercise or conversion ($12.9K) · Sold 4,360 shares ($116K)
05 Nov 2018	Form 4/A: Halak Brian K, 10% owner Sold 245,096 shares ($3.41M) · Sold 129,629 shares ($1.76M) · Sold 190,275 shares ($2.54M)
08 May 2014	Form 4/A: Kolchinsky Peter, Director Granted 25,000 Director Stock Option (right to buy)
30 Apr 2014	Form 4/A: Halak Brian K, Director Granted 25,000 Stock Option (Right to Buy)
21 Apr 2014	Form 4/A: Langer Dennis, Director Received 95,014 shares by conversion
20 Feb 2014	Form 4/A: Langer Dennis, Director Granted 50,000 Employee Stock Option (right to buy) · Received 8,873 shares by exercise or conversion ($30.3K) · Received 90,014 shares by conversion

Comments